Literature DB >> 33160798

Group Lifestyle Balance Adapted for Individuals With Impaired Mobility: Outcomes for 6-Month RCT and Combined Groups at 12 Months.

Katherine Froehlich-Grobe1, Andrea C Betts2, Simon J Driver3, Danielle N Carlton4, Amber Merfeld Lopez3, Jaehoon Lee5, M Kaye Kramer6.   

Abstract

INTRODUCTION: This study examines the feasibility and effectiveness of an intensive lifestyle intervention adapted for people with impaired mobility. STUDY
DESIGN: This was a randomized, wait-list controlled trial. The experimental group immediately received the 12-month weight loss program; the wait-list control group received it after a 6-month delay. Between-group comparisons were conducted for the 6-month RCT study design. Repeated measures were conducted for both groups combined after receiving the 12-month intervention. Data were collected August 2015-February 2017 and analyzed in 2017. SETTING/PARTICIPANTS: A community-based sample received 23, group-based sessions via a mix of telephone and in-person sessions in a hospital-based setting. Participants with impaired mobility (n=66) were middle-aged (49.80 [SD=11.37] years), mostly White (66.7%), female (66.7%), and most commonly had spinal cord injury (47.0%). INTERVENTION: The 12-month intervention delivered 23 group-based sessions that promoted weight loss through reducing caloric intake and increasing physical activity. MAIN OUTCOME MEASURES: Primary outcomes were effectiveness measured as change in weight and time spent in moderate physical activity. Feasibility was assessed in 12-month combined group analyses, measured as retention, attendance, and dietary self-monitoring.
RESULTS: The 6-month RCT results showed that the immediate and delayed groups differed significantly (p<0.05) in weight (-1.66 [SD=4.42] kg loss vs 0.05 [SD=4.15] kg gain) and moderate physical activity (52.93 [SD=90.74] minutes/week increase vs -14.22 [SD=96.02] minutes/week decrease), accounting for baseline weight, time with disability, and age of onset. The 12-month results with groups combined demonstrated 74.2% retention and 77.7% core session attendance. Self-monitoring was higher in the delayed group (77.3%), who used a smartphone app, than the immediate group (47.3%), who mostly used paper trackers. Participants achieved significant 12-month weight loss of 3.31 (SD=10.13) kg (d=0.33) in mixed modeling analyses with groups combined yet did not significantly increase moderate physical activity.
CONCLUSIONS: Group Lifestyle Balance Adapted for Individuals with Impaired Mobility is a feasible, effective approach to teach healthy lifestyle skills to individuals with mobility impairment, yielding modest weight loss and enhanced self-efficacy. TRIAL REGISTRATION: This study is registered at www.clinicaltrials.gov NCT03307187.
Copyright © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33160798      PMCID: PMC7810163          DOI: 10.1016/j.amepre.2020.06.023

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  47 in total

1.  Screening for obesity in adults: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2003-12-02       Impact factor: 25.391

2.  Differences in resting metabolic rate between paraplegic and able-bodied subjects are explained by differences in body composition.

Authors:  Andrea C Buchholz; Colleen F McGillivray; Paul B Pencharz
Journal:  Am J Clin Nutr       Date:  2003-02       Impact factor: 7.045

3.  International physical activity questionnaire: 12-country reliability and validity.

Authors:  Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja
Journal:  Med Sci Sports Exerc       Date:  2003-08       Impact factor: 5.411

4.  Accessible weight loss: Adapting a lifestyle intervention for adults with impaired mobility.

Authors:  Andrea C Betts; Katherine Froehlich-Grobe
Journal:  Disabil Health J       Date:  2016-06-21       Impact factor: 2.554

5.  Recruitment for a Diabetes Prevention Program translation effort in a worksite setting.

Authors:  J Taradash; M Kramer; D Molenaar; V Arena; K Vanderwood; Andrea M Kriska
Journal:  Contemp Clin Trials       Date:  2015-01-26       Impact factor: 2.226

6.  Accessibility of health clubs for people with mobility disabilities and visual impairments.

Authors:  James H Rimmer; Barth Riley; Edward Wang; Amy Rauworth
Journal:  Am J Public Health       Date:  2005-11       Impact factor: 9.308

7.  Standard and Amputation-Adjusted Body Mass Index Measures: Comparison and Relevance to Functional Measures, Weight-Related Comorbidities, and Dieting.

Authors:  Christopher Kevin Wong; Ryan J Wong
Journal:  Am J Phys Med Rehabil       Date:  2017-12       Impact factor: 2.159

8.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.

Authors:  Katherine M Flegal; Margaret D Carroll; Brian K Kit; Cynthia L Ogden
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

Review 9.  Necessary components for lifestyle modification interventions to reduce diabetes risk.

Authors:  Elizabeth M Venditti; M Kaye Kramer
Journal:  Curr Diab Rep       Date:  2012-04       Impact factor: 4.810

10.  Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

Authors:  William L Haskell; I-Min Lee; Russell R Pate; Kenneth E Powell; Steven N Blair; Barry A Franklin; Caroline A Macera; Gregory W Heath; Paul D Thompson; Adrian Bauman
Journal:  Med Sci Sports Exerc       Date:  2007-08       Impact factor: 5.411

View more
  1 in total

1.  Barriers and Facilitators to Lifestyle Intervention Engagement and Weight Loss in People Living With Spinal Cord Injury.

Authors:  Andrea C Betts; Christa Ochoa; Rita Hamilton; Seema Sikka; Katherine Froehlich-Grobe
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.